title: New imaging paradigms in drug development: the PET imaging approach.
abstract: Molecular imaging is becoming an indispensable part of clinical drug development. The presented review highlights few state-of-the-art examples that serve to illustrate specific points and discuss future directions of the use of positron emission tomography (PET) imaging in various phases of clinical drug development.:
authors.affiliation: Genentech Research and Early Development (gRED), Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address:marik.jan@gene.com.
authors.forename: Jan
authors.initials: J
authors.lastname: Marik
authors.affiliation: Genentech Research and Early Development (gRED), Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
authors.forename: Sandra M Sanabria
authors.initials: SM
authors.lastname: Bohorquez
authors.affiliation: Genentech Research and Early Development (gRED), Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
authors.forename: Simon-Peter
authors.initials: SP
authors.lastname: Williams
authors.affiliation: Genentech Research and Early Development (gRED), Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
authors.forename: Nicholas
authors.initials: N
authors.lastname: van Bruggen